Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Others possible symptoms include nausea and vomiting, bloating, loss of appetite and heartburn. Complications may include bleeding, stomach ulcers, and stomach tumors.
This report aims to provide a comprehensive presentation of the global market for Gastritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastritis Therapeutics. This report contains market size and forecasts of Gastritis Therapeutics in global, including the following market information:
Global Gastritis Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Gastritis Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Americas is going to account for the largest share for gastritis treatment market. Drivers such as widespread of fast food chains in this region along with the increasing sedentary life culture which in turn contributes to increasing patient pool of gastritis and rising geriatric population are likely to enhance the growth of gastritis treatment market.
We surveyed the Gastritis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastritis Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Gastritis Therapeutics Market Segment Percentages, by Type, 2022 (%)
Acid-Blocking Medicines
Antibiotics
Antacids
Histamine Blockers
Others
Global Gastritis Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Gastritis Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Gastritis Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Gastritis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastritis Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gastritis Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Novartis
Cipla
Abbott Laboratories
Microbiotix
Reddy's Laboratories
Lupin Ltd
Perrigo Pharmaceutical
Sun Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastritis Therapeutics, market overview.
Chapter 2: Global Gastritis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Gastritis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastritis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastritis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastritis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastritis Therapeutics Overall Market Size
2.1 Global Gastritis Therapeutics Market Size: 2022 VS 2030
2.2 Global Gastritis Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gastritis Therapeutics Players in Global Market
3.2 Top Global Gastritis Therapeutics Companies Ranked by Revenue
3.3 Global Gastritis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Gastritis Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gastritis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastritis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Gastritis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Gastritis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastritis Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Acid-Blocking Medicines
4.1.3 Antibiotics
4.1.4 Antacids
4.1.5 Histamine Blockers
4.1.6 Others
4.2 By Type - Global Gastritis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Gastritis Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Gastritis Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Gastritis Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastritis Therapeutics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Gastritis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Gastritis Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Gastritis Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Gastritis Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Gastritis Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Gastritis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Gastritis Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Gastritis Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Gastritis Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Gastritis Therapeutics Revenue, 2018-2030
6.3.2 US Gastritis Therapeutics Market Size, 2018-2030
6.3.3 Canada Gastritis Therapeutics Market Size, 2018-2030
6.3.4 Mexico Gastritis Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Gastritis Therapeutics Revenue, 2018-2030
6.4.2 Germany Gastritis Therapeutics Market Size, 2018-2030
6.4.3 France Gastritis Therapeutics Market Size, 2018-2030
6.4.4 U.K. Gastritis Therapeutics Market Size, 2018-2030
6.4.5 Italy Gastritis Therapeutics Market Size, 2018-2030
6.4.6 Russia Gastritis Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Gastritis Therapeutics Market Size, 2018-2030
6.4.8 Benelux Gastritis Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Gastritis Therapeutics Revenue, 2018-2030
6.5.2 China Gastritis Therapeutics Market Size, 2018-2030
6.5.3 Japan Gastritis Therapeutics Market Size, 2018-2030
6.5.4 South Korea Gastritis Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Gastritis Therapeutics Market Size, 2018-2030
6.5.6 India Gastritis Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Gastritis Therapeutics Revenue, 2018-2030
6.6.2 Brazil Gastritis Therapeutics Market Size, 2018-2030
6.6.3 Argentina Gastritis Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gastritis Therapeutics Revenue, 2018-2030
6.7.2 Turkey Gastritis Therapeutics Market Size, 2018-2030
6.7.3 Israel Gastritis Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Gastritis Therapeutics Market Size, 2018-2030
6.7.5 UAE Gastritis Therapeutics Market Size, 2018-2030
7 Gastritis Therapeutics Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Gastritis Therapeutics Major Product Offerings
7.1.4 Pfizer Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Gastritis Therapeutics Major Product Offerings
7.2.4 AstraZeneca Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Gastritis Therapeutics Major Product Offerings
7.3.4 Novartis Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Gastritis Therapeutics Major Product Offerings
7.4.4 Cipla Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Company Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories Gastritis Therapeutics Major Product Offerings
7.5.4 Abbott Laboratories Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Abbott Laboratories Key News & Latest Developments
7.6 Microbiotix
7.6.1 Microbiotix Company Summary
7.6.2 Microbiotix Business Overview
7.6.3 Microbiotix Gastritis Therapeutics Major Product Offerings
7.6.4 Microbiotix Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Microbiotix Key News & Latest Developments
7.7 Reddy's Laboratories
7.7.1 Reddy's Laboratories Company Summary
7.7.2 Reddy's Laboratories Business Overview
7.7.3 Reddy's Laboratories Gastritis Therapeutics Major Product Offerings
7.7.4 Reddy's Laboratories Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Reddy's Laboratories Key News & Latest Developments
7.8 Lupin Ltd
7.8.1 Lupin Ltd Company Summary
7.8.2 Lupin Ltd Business Overview
7.8.3 Lupin Ltd Gastritis Therapeutics Major Product Offerings
7.8.4 Lupin Ltd Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Lupin Ltd Key News & Latest Developments
7.9 Perrigo Pharmaceutical
7.9.1 Perrigo Pharmaceutical Company Summary
7.9.2 Perrigo Pharmaceutical Business Overview
7.9.3 Perrigo Pharmaceutical Gastritis Therapeutics Major Product Offerings
7.9.4 Perrigo Pharmaceutical Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Perrigo Pharmaceutical Key News & Latest Developments
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Company Summary
7.10.2 Sun Pharmaceutical Industries Business Overview
7.10.3 Sun Pharmaceutical Industries Gastritis Therapeutics Major Product Offerings
7.10.4 Sun Pharmaceutical Industries Gastritis Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Sun Pharmaceutical Industries Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gastritis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Gastritis Therapeutics Market Drivers in Global Market
Table 3. Gastritis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Gastritis Therapeutics in Global Market
Table 5. Top Gastritis Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gastritis Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gastritis Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gastritis Therapeutics Product Type
Table 9. List of Global Tier 1 Gastritis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastritis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gastritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Gastritis Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gastritis Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Gastritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Gastritis Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gastritis Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Gastritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Gastritis Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gastritis Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Gastritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gastritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Gastritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gastritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Gastritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gastritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Gastritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gastritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Gastritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gastritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Gastritis Therapeutics Product Offerings
Table 32. Pfizer Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Gastritis Therapeutics Product Offerings
Table 36. AstraZeneca Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Gastritis Therapeutics Product Offerings
Table 40. Novartis Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Cipla Company Summary
Table 43. Cipla Gastritis Therapeutics Product Offerings
Table 44. Cipla Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Cipla Key News & Latest Developments
Table 46. Abbott Laboratories Company Summary
Table 47. Abbott Laboratories Gastritis Therapeutics Product Offerings
Table 48. Abbott Laboratories Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Laboratories Key News & Latest Developments
Table 50. Microbiotix Company Summary
Table 51. Microbiotix Gastritis Therapeutics Product Offerings
Table 52. Microbiotix Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Microbiotix Key News & Latest Developments
Table 54. Reddy's Laboratories Company Summary
Table 55. Reddy's Laboratories Gastritis Therapeutics Product Offerings
Table 56. Reddy's Laboratories Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Reddy's Laboratories Key News & Latest Developments
Table 58. Lupin Ltd Company Summary
Table 59. Lupin Ltd Gastritis Therapeutics Product Offerings
Table 60. Lupin Ltd Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Lupin Ltd Key News & Latest Developments
Table 62. Perrigo Pharmaceutical Company Summary
Table 63. Perrigo Pharmaceutical Gastritis Therapeutics Product Offerings
Table 64. Perrigo Pharmaceutical Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Perrigo Pharmaceutical Key News & Latest Developments
Table 66. Sun Pharmaceutical Industries Company Summary
Table 67. Sun Pharmaceutical Industries Gastritis Therapeutics Product Offerings
Table 68. Sun Pharmaceutical Industries Gastritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Sun Pharmaceutical Industries Key News & Latest Developments
List of Figures
Figure 1. Gastritis Therapeutics Segment by Type in 2022
Figure 2. Gastritis Therapeutics Segment by Application in 2022
Figure 3. Global Gastritis Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastritis Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Gastritis Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastritis Therapeutics Revenue in 2022
Figure 8. By Type - Global Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Gastritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Gastritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Gastritis Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Gastritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cipla Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Laboratories Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Microbiotix Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Reddy's Laboratories Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lupin Ltd Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Perrigo Pharmaceutical Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sun Pharmaceutical Industries Gastritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
